1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62D1B70F7C3CEB72865257B870015D1AA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/pharmaceutical-library-services-financial-staffing-resources?opendocument
18
19opendocument
2098.80.143.34
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Business Operations » Corporate Libraries

Pharmaceutical Library Services: Financial & Staffing Resources

ID: 5250


Features:

3 Info Graphics

11 Data Graphics

74 Metrics


Pages/Slides: 23


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Pharmaceutical Library Services: Financial & Staffing Resources"


STUDY OVERVIEW

With shrinking resources and increasing pressure for services, corporate libraries and information centers are struggling to balance their budget and staffing levels while providing services that demonstrate their value to their organization. To deal with these challenges, library leaders need to effectively balance their budgets and resources with service volumes that have the greatest impact for their internal customers.

Best Practices, LLC conducted this research to help library and information center leaders compare their budget and staffing with those at other organizations within the biopharmaceutical industry.


KEY TOPICS

  • Financial resources
  • Cost recovery practices
  • Distribution of FTE hours by service category
  • Penetration of potential user base


SAMPLE KEY METRICS

  • Number of potential and actual users of library services
  • Total cost of providing library services
  • Cost per potential and actual user
  • What method, if any, does library use to recover costs for its services
  • Percentage of FTE hours dedicated to various support services
SAMPLE KEY FINDING
  • Cost Recovery: The most common cost-recovery method in use by participants is charging heavy user groups for the cost of expensive, specialized, niche resources. In the Device Segment, none of the participating companies recover costs, while 43% of Pharma Segment companies do.


METHODOLOGY

Twenty-one companies participated in this study, with 16 representing the pharmaceutical/ biotech industries and five representing the medical device/ diagnostic industries.


Industries Profiled:
Pharmaceutical; Biotech; Chemical; Health Care; Biopharmaceutical; Manufacturing; Medical Device; Medical; Science; Orthopaedics


Companies Profiled:
Abbvie; Biogen Idec; Boehringer Ingelheim; Celgene; Cubist Pharmaceuticals; Daiichi Sankyo; Eisai; Ferring Pharmaceuticals; Forest Laboratories; Inc; Gilead Sciences; Mallinckrodt; Novo Nordisk; Purdue Pharma; UCB Pharma; Vertex Pharmaceuticals; Covidien; Hologic; St. Jude Medical; Thermo Fisher Scientific; Zimmer

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.